Please assess the completion status of the following clinical trial:

Trial Title: An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* No prior treatment with botulinum toxin Type A for treatment of iOAB~Exclusion Criteria:~* Treatment with any botulinum toxin Type A within 18 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients With Urinary Incontinence Due to iOAB (Type: None): Patients with urinary incontinence due to iOAB treated with BOTOX® in accordance with physician standard practice.

Based on this trial design, predict the completion outcome and termination type (if applicable).